These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 27998790)
41. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification. Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283 [TBL] [Abstract][Full Text] [Related]
42. A stroma-related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early-stage colon cancer. Zhou R; Sun H; Zheng S; Zhang J; Zeng D; Wu J; Huang Z; Rong X; Bin J; Liao Y; Shi M; Liao W J Cell Mol Med; 2020 Mar; 24(5):3229-3241. PubMed ID: 31989761 [TBL] [Abstract][Full Text] [Related]
43. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis. Dong S; Ding Z; Zhang H; Chen Q Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719 [No Abstract] [Full Text] [Related]
44. Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer. Shi C; Yang Y; Zhang L; Zhang T; Yu J; Qin S; Gao Y Oncol Rep; 2019 Jun; 41(6):3167-3178. PubMed ID: 30942460 [TBL] [Abstract][Full Text] [Related]
45. Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice. Liu J; Dong C; Jiang G; Lu X; Liu Y; Wu H BMC Med Genomics; 2020 Sep; 13(Suppl 9):135. PubMed ID: 32957968 [TBL] [Abstract][Full Text] [Related]
46. Construction of a 5-feature gene model by support vector machine for classifying osteoporosis samples. Hu M; Zou L; Lu J; Yang Z; Chen Y; Xu Y; Sun C Bioengineered; 2021 Dec; 12(1):6821-6830. PubMed ID: 34622712 [TBL] [Abstract][Full Text] [Related]
47. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018 [TBL] [Abstract][Full Text] [Related]
48. Four microRNAs Signature for Survival Prognosis in Colon Cancer using TCGA Data. Xu J; Zhao J; Zhang R Sci Rep; 2016 Dec; 6():38306. PubMed ID: 27974852 [TBL] [Abstract][Full Text] [Related]
49. INHBA is a prognostic predictor for patients with colon adenocarcinoma. Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338 [TBL] [Abstract][Full Text] [Related]
50. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma. Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920 [TBL] [Abstract][Full Text] [Related]
51. Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes. Zlobec I; Terracciano LM; Lugli A Clin Cancer Res; 2008 Jun; 14(12):3792-7. PubMed ID: 18559598 [TBL] [Abstract][Full Text] [Related]
52. A novel prognostic signature of seven genes for the prediction in patients with thymoma. Li Q; Su YL; Shen WX J Cancer Res Clin Oncol; 2019 Jan; 145(1):109-116. PubMed ID: 30328513 [TBL] [Abstract][Full Text] [Related]
53. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
54. Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer. Zhang C; Sun Q J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):319-325. PubMed ID: 28585144 [TBL] [Abstract][Full Text] [Related]
56. Tumor microenvironment derived signature predicting relapse-free survival in I-III cancer and preliminary experiment verification. Zhang Z; Wu Q; Zhu D; He G; Feng Q; Xu J Int Immunopharmacol; 2021 Feb; 91():107243. PubMed ID: 33321467 [TBL] [Abstract][Full Text] [Related]
57. A recurrence model for laryngeal cancer based on SVM and gene function clustering. Su J; Zhang Y; Su H; Zhang C; Li W Acta Otolaryngol; 2017 May; 137(5):557-562. PubMed ID: 27809638 [TBL] [Abstract][Full Text] [Related]
58. High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment. Ge W; Hu H; Cai W; Xu J; Hu W; Weng X; Qin X; Huang Y; Han W; Hu Y; Yu J; Zhang W; Ye S; Qi L; Huang P; Chen L; Ding K; Wang LD; Zheng S Int J Cancer; 2020 Apr; 146(7):2027-2035. PubMed ID: 31693169 [TBL] [Abstract][Full Text] [Related]
59. Identifying a Risk Signature of Methylation-Driven Genes as a Predictor of Survival Outcome for Colon Cancer Patients. Zhao B; Wang J; Sheng G; Wang Y; Yang T; Meng K Appl Biochem Biotechnol; 2024 Jul; 196(7):4156-4165. PubMed ID: 37906409 [TBL] [Abstract][Full Text] [Related]
60. Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma. Shang J; Wang F; Chen P; Wang X; Ding F; Liu S; Zhao Q Dig Dis Sci; 2018 May; 63(5):1219-1228. PubMed ID: 29497907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]